Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo de revisión (ReviewArticle)

Personalized prevention of neurodegenerative diseases: scoping review and evidence gap map

  • Barahona-López, Cristina
  • Plans-Beriso, Elena
  • Diez‐Echave, Paul
  • Hernández, Orlando
  • Fernandez de Larrea-Baz, Nerea
  • Craciun, Oana Marilena
  • García-Ovejero, Ester
  • Petrova, Dafina
  • Fernández‐Martínez, Nicolás Francisco
  • Arruabarrena‐Blanco, Estíbaliz
  • Babb‐de‐Villiers, Chantal
  • Turner, Heather
  • Jimenez, Ramon Cierco
  • Erady, Chaitanya
  • Wilson, Hayley
  • Fernandez-Navarro, Pablo L
  • García-Esquinas, Esther
  • Kuhn, Isla
  • Sánchez, Pascual
  • Rodríguez‐Artalejo, Fernando
  • Sánchez, María José
  • Moreno, Víctor
  • Blackburn, Laura
  • Pollan-Santamaria, Marina
  • Kroese, Mark
  • Perez-Gomez, Beatriz
Neurodegenerative diseases represent a major public health challenge due to their high prevalence and poor prognosis. Identifying biomarkers to stratify individuals by their risk of developing these diseases may help to define new personalized prevention interventions. The objective of this study was to conduct a scoping review of biomarkers for primary and secondary personalized prevention of neurodegenerative diseases. The search targeted biomarkers in adults or high‐risk subpopulations in clinical or public health settings for Alzheimer's disease, vascular dementia, Lewy body disease, frontotemporal dementia, Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis. Ultimately, 286 papers were included in the review and the interactive gap map. There is a strong focus on Alzheimer's disease, and most papers included ‐omics‐based biomarkers and/or used artificial intelligence. Genetics/genomics are at the forefront of current scientific research, although there is a notable gap in studying gene–environment interactions, and studies in clinical settings are still scarce. Highlights: Research indicates a strong focus on Alzheimer´s disease and limited research in other diseases. Genetics and genomics are at the forefront of current scientific research. We found biomarkers for predicting progression in mild cognitive decline. There is a notable gap in studying gene‐environment interactions. Studies investigating biomarkers in a clinical context are still scarce.
Repisalud
Datos de investigación Set de datos (Dataset)

Interactive Gap Maps on Available Biomarkers for Risk Prediction and Stratification in Cancer, Cardiovascular, and Neurodegenerative Diseases (PROPHET Project)

  • Plans-Beriso, Elena
  • Babb-de-Villiers, Chantal
  • Petrova, Dafina
  • Barahona-López, Cristina
  • Diez-Echave, Paul
  • Hernández, Orlando
  • Fernández-Martínez, Nicolás Francisco
  • Turner, Heather
  • García-Ovejero, Ester
  • Craciun, Oana Marilena
  • Fernandez-Navarro, Pablo L
  • Fernandez de Larrea-Baz, Nerea
  • García-Esquinas, Esther
  • Kuhn, Isla
  • Jimenez-Planet, Virginia
  • Rodríguez-Artalejo, Fernando
  • Sánchez, María-José
  • Pollan-Santamaria, Marina
  • Blackburn, Laura
  • Kroese, Mark
  • Perez-Gomez, Beatriz
[EN] The PROPHET project (“PeRsOnalized Prevention roadmap for the future HEalThcare”), funded by the European Union's Horizon Europe research and innovation program, aims to assess the effectiveness, clinical utility, key success factors, and gaps in personalised preventive approaches for healthcare settings. One of the main task focuses on biomarkers for personalised prevention in the general adult population and their integration with digital technologies. The objective of the task is to highlight gaps in biomarkers research for primary and secondary prevention for cancer, cardiovascular, and neurodegenerative diseases. Three rapid scoping reviews were conducted in parallel by three research teams, one for each group of diseases: cancer, cardiovascular and neurodegenerative diseases. The reviews used a common protocol and framework for searching, data extraction and the representation of results, with disease specific corresponding information and specifications. The following evidence and gap map is a product of these scoping reviews. [ES] El proyecto PROPHET (“PeRsOnalized Prevention roadmap for the future HEalThcare”), financiado por el programa de investigación e innovación Horizonte Europa de la Unión Europea, tiene como objetivo evaluar la eficacia, la utilidad clínica, los factores clave de éxito y las lagunas en los enfoques preventivos personalizados para entornos sanitarios. Una de las principales tareas se centra en los biomarcadores para la prevención personalizada en la población adulta general y su integración con las tecnologías digitales. El objetivo de la tarea es resaltar las lagunas en la investigación de biomarcadores para la prevención primaria y secundaria del cáncer, enfermedades cardiovasculares y neurodegenerativas. Tres equipos de investigación llevaron a cabo en paralelo tres revisiones rápidas de alcance, una para cada grupo de enfermedades: cáncer, enfermedades cardiovasculares y neurodegenerativas. Las revisiones utilizaron un protocolo y un marco común para la búsqueda, la extracción de datos y la representación de los resultados, con la información y especificaciones correspondientes específicas de la enfermedad. La siguiente evidencia y mapa de brechas es producto de estas revisiones de alcance.